Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

Por Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M., Ma, Wen Wee, Miller, Austin, Adjei, Alex A., Dy, Grace K.
Publicado no Cancers (Basel) (2017)

A phase Ib study of the FGFR/VEGFR inhibitor dovitinib with gemcitabine and capecitabine in advanced solid tumor and pancreatic cancer patients

Por Ma, Wen Wee, Xie, Hao, Fetterly, Gerald, Pitzonka, Laura, Whitworth, Amy, LeVea, Charles, Wilton, John, Mantione, Krystin, Schihl, Sarah, Dy, Grace K, Boland, Patrick, Iyer, Renuka, Tan, Wei, Brady, William, Straubinger, Robert M, Adjei, Alex A
Publicado no Am J Clin Oncol (2019)